TruAge epigenetic clock testing and biological age tracking
TruAge epigenetic clock testing is one of the core tools ABL Wellness Clinic uses to move longevity medicine beyond guesswork. The test adds context around inflammation and biological aging signals so your plan starts with a measurable baseline instead of guesswork. For many patients, this is the first time “aging” becomes something measurable instead of abstract. It can help answer how your aging-biology and inflammation signals fit into the broader clinical picture.
The most important value of TruAge is not simply the first number. The value comes from using it as a baseline and then retesting after meaningful interventions. If a patient improves sleep, blood pressure, glucose control, body composition, inflammation, nutrition, VO2 Max, or hormone balance, repeat testing may help show whether the overall trajectory is moving in the right direction. Results vary and no test can guarantee health outcomes, but measurable feedback helps patients stay engaged and helps clinicians refine protocols.
ABL uses TruAge within a complete clinical context. We do not interpret biological age testing with an epigenetic clock by itself. The number is reviewed alongside labs, body composition, blood pressure, fitness testing, symptoms, medications, family history, sleep risk, and patient goals. The goal is to convert data into action: what should improve first, what can wait, and how will progress be measured? TruAge is included in the Foundational Longevity Assessment and may be repeated when clinically appropriate according to the patient’s plan.
See packages with TruAgeCircleDNA genetic risk assessment for personalized prevention
CircleDNA helps ABL Wellness Clinic understand inherited risk patterns that may affect prevention planning. Unlike TruAge, which can be repeated to help track biological aging and inflammation signals, CircleDNA is a static genetic assessment. It can help identify whether a patient carries genes associated with increased risk for certain health conditions, how the body may metabolize medications, and how genetic traits may influence exercise response, caffeine response, and other lifestyle factors.
Patients often want to know about Alzheimer’s risk, ApoE4, cancer risk, medication metabolism, and whether they are likely to respond quickly or slowly to certain training strategies. CircleDNA can provide insight into some of these areas, but it must be interpreted carefully. Genes are not destiny. A risk marker does not mean a condition will occur, and a reassuring result does not remove the need for screening, prevention, or healthy habits. ABL uses genetic information to prioritize prevention before problems develop.
When concerning findings appear, genetic counseling may be recommended. This is especially important for cancer risk markers, ApoE4 findings, or other results that could affect family members or major medical decisions. CircleDNA is included in the Foundational Longevity Assessment and can support personalized prevention planning when appropriate. The clinical purpose is not fear; it is targeted prevention, better screening conversations, and a more personalized health-span plan.
Compare TruAge and CircleDNAVO2 Max, DEXA, bioimpedance, and body composition tracking
Fitness and body composition are among the strongest practical signals in longevity medicine. VO2 Max reflects cardiorespiratory fitness and is strongly associated with long-term health and functional capacity. Improving VO2 Max is essential for many longevity plans because it reflects the body’s ability to deliver and use oxygen during exertion. ABL may use a validated bicycle or treadmill protocol in the Foundational Assessment and more advanced cardiopulmonary exercise testing as an add-on when appropriate.
Body composition matters because weight alone does not tell the full story. A patient can lose weight but also lose muscle, or remain the same weight while improving lean mass and visceral fat. ABL uses bioimpedance to estimate muscle mass, visceral fat, nourishment status, and trends over time. As an advanced diagnostic add-on, DEXA adds deeper assessment of body composition and bone density. These measurements help determine whether nutrition, exercise, medication, hormone, or fasting interventions are producing the desired effect.
Tracking is the difference between activity and optimization. ABL memberships include repeat testing at defined intervals, such as quarterly body composition tracking in Silver and VO2 Max and Resting Metabolic Rate analysis every 6 months in Gold. The goal is to turn broad advice—“exercise more” or “lose fat”—into measurable targets tied to the patient’s ABL Longevity Score and long-term health-span priorities.
Compare tracking by tierAdvanced labs, blood pressure optimization, and ABL Longevity Score
The ABL lab strategy focuses on markers that help clarify cardiovascular, metabolic, inflammatory, hormonal, and nutritional risk. Baseline labs may include ApoB, HOMA-IR, Lp(a), lipid panel, CMP, CBC, hs-CRP, vitamin D, TSH, testosterone, estrogen, and other clinically appropriate markers. These results are interpreted by the physician and synthesized with blood pressure, body composition, VO2 Max, questionnaires, symptoms, and genetic data.
Blood pressure optimization is emphasized because it is one of the most modifiable longevity risk factors. ABL uses calibrated readings over multiple time points to avoid relying on one rushed measurement. Home monitoring and coaching are included in membership tiers because consistent blood pressure control often requires patient education, medication review when appropriate, lifestyle adjustment, and follow-up.
The ABL Longevity Score brings this information together into a prioritized portfolio. Rather than giving patients a long list of disconnected recommendations, the score helps organize what matters most now: lipids, insulin resistance, inflammation, sleep apnea risk, body composition, fitness, hormones, gut health, cognitive risk, or adherence. Quarterly score recalculation in memberships helps patients see whether interventions are working and where protocols should be refined.
Request an ABL Score consultationObesity management and GLP-1 protocol support
The Obesity Management Protocol is designed for patients who need medically guided weight loss optimization, including GLP-1 assessment, prescription coordination, and monthly monitoring. Weight loss is treated as a metabolic and longevity issue rather than a cosmetic goal alone. Body composition, blood pressure, glucose patterns, protein intake, muscle preservation, side effects, medication response, and adherence are all considered.
ABL notes approximate program costs separately from membership: about $500 per month when compounded semaglutide is included, and about $250 for routine monitoring when prescription GLP-1 agonists are obtained separately. Costs and availability may vary and should be confirmed directly with the clinic. This program is billed through ABL Medical Spa according to the current business process.
GLP-1 therapy is not appropriate for everyone. Screening should include medical history, medication review, contraindications, gastrointestinal history, pancreatitis risk, gallbladder history, pregnancy status, and expectations. ABL’s longevity approach also emphasizes strength training, nutrition, and body composition tracking so weight loss supports health span rather than causing muscle loss or rebound.
Ask about obesity managementHormone optimization program
The Hormone Optimization Program is for patients seeking bioidentical hormone therapy or hormone optimization in a monitored clinical setting. The program includes a complete hormone panel, therapy initiation when appropriate, and monthly follow-ups. Approximate cost is $400 per month, separate from membership, and billed through ABL Medical Spa. Patients should confirm current pricing and eligibility directly with the clinic.
Hormone optimization may address symptoms related to menopause, perimenopause, low testosterone, thyroid imbalance, fatigue, sleep, libido, body composition, or recovery. However, hormone therapy should never be based on symptoms alone or on a desire to “anti-age” without safety review. ABL considers labs, health history, cancer risk, cardiovascular risk, clotting risk, sleep apnea risk, medication use, fertility goals, and patient preferences.
When hormone therapy is appropriate, follow-up matters. Dosing, symptom response, lab monitoring, side effects, blood pressure, and overall risk profile should be reviewed regularly. Hormone optimization can also interact with other longevity interventions such as GLP-1 therapy, nutrition planning, peptide management, sleep optimization, and fitness training. The goal is safer, more precise optimization rather than trend-driven prescribing.
Discuss hormone optimization